Montalbo R. et. al., 2018 Prognostic value of circulating microRNAs in upper tract urinary carcinoma, 10.18632/oncotarget.24672, Oncotarget, Mar 30, 2018 ➔

Vasudevan H.N. et. al., 2018 Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation., 10.1016/j.celrep.2018.03.013., Cell Reports, Mar 27, 2018 ➔

A.D. et. al., 2018 Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin., 10.1016/j.ebiom.2018.03.022, EBIoMedicine, Mar 21, 2018 ➔

Araujo J.M. et. al., 2018 Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer, 10.1038/s41598-018-23099-7, Sci. Reports, Mar 20, 2018 ➔

Giordano M. et. al., 2018 Differential microRNA expression profiles between young and old lung adenocarcinoma patients, 10(3): 892–900. , Am J. Trans. Res., Mar 15, 2018 ➔

Arend R.C. et. al., 2018 Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma., 10.1158/1541-7786.MCR-17-0594, Mol. Can. Res., Mar 08, 2018 ➔

Cosphiadi I. et. al., 2018 Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray., 10.1016/j.clbc.2018.03.001., Clin Breast Can., Mar 08, 2018 ➔

Wagle M-C. et. al., 2018 A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types, 10.1038/s41698-018-0051-4, http://www.nature.com/articles/s41698-018-0051-4, Mar 07, 2018 ➔

Yamaguchi S. et. al., 2018 Molecular and clinical features of the TP53 signature gene expression profile in early-stage breast cancer., 10.18632/oncotarget.24447, Oncotarget, Mar 06, 2018 ➔

Nakazawa Y. et. al., Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer, 10.1038/s41598-018-22340-7, Sci. Reports, Mar 05, 2018 ➔

Huet S. et. al., A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts, 10.1016/S1470-2045(18)30102-5, The Lancet, Feb 20, 2018 ➔

Baumgartner U. et. al., miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer, 10.1186/s12943-018-0781-5, Mol. Cancer, Feb 19, 2018 ➔

Vari F. et. al., Immune evasion via PD-1/PD-L1 on NK-cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL., 10.1182/blood-2017-07-796342, Blood, Feb 15, 2018 ➔

Sestak I. et. al., Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial., 10.1001/jamaoncol.2017.5524, JAMA Oncol., Feb 15, 2018 ➔

Shi L. et. al., KRAS induces lung tumorigenesis through microRNAs modulation, 10.1038/s41419-017-0243-9, Cell Death and Disease, Feb 13, 2018 ➔